Purification and application of C-terminally truncated hepatitis C virus E1 proteins expressed in Escherichia coli

World Journal of Gastroenterology

Volumn 11, Issue 4, 2005, Pages 503-507

  Liu, Jing ^a   Zhu, Li Xin ^a   Kong, Yu Ying ^a   Li, Guang Di ^a   Wang, Yuan ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Escherichia coli; HCV envelope protein 1; Recombinant fusion proteins

Indexed keywords

ANTISERUM; EPITOPE; GLYCOPROTEIN E1; HEPATITIS C VACCINE; HISTIDINE; HYBRID PROTEIN; NICKEL; NITRILOTRIACETIC ACID; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG RESEARCH; ESCHERICHIA COLI; EXPRESSION VECTOR; HEPATITIS C; HEPATITIS C VIRUS; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; IMMUNIZATION; MAMMAL CELL; MEDICAL RESEARCH; NONHUMAN; PROKARYOTE; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RABBIT; WESTERN BLOTTING;

EID: 13244287999     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i4.503     Document Type: Article

References (29)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362
2. Cohen J. The scientific challenge of hepatitis C. Science 1999; 285: 26-30
3. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999; 6: 35-47
4. Seeff LB. Natural history of hepatitis C. Am J Med 1999; 107: 10S-15S
5. Wawrzynowicz-Syczewska M, Kubicka J, Lewandowski Z, Boron-Kaczmarska A, Radkowski M. Natural history of acute symptomatic hepatitis type C. Infection 2004; 32: 138-143
6. Kew M, Francois G, Lavanchy D, Margolis H, Van Damme P, Grob P, Hallauer J, Shouval D, Leroux-Roels G, Meheus A. Prevention of hepatitis C virus infection. J Viral Hepat 2004; 11: 198-205
7. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339: 1485-1492
8. Zein CO, Zein NN. Advances in therapy for hepatitis C infection. Microbes Infect 2002; 4: 1237-1246
9. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993; 67: 1385-1395
10. Selby MJ, Choo QL, Berger K, Kuo G, Glazer E, Eckart M, Lee C, Chien D, Kuo C, Houghton M. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol 1993; 74(Pt 6): 1103-1113
11. Garcia JE, Puentes A, Suarez J, Lopez R, Vera R, Rodriguez LE, Ocampo M, Curtidor H, Guzman F, Urquiza M, Patarroyo ME. Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells. J Hepatol 2002; 36: 254-262
12. Lagging LM, Meyer K, Owens RJ, Ray R. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus. J Virol 1998; 72: 3539-3546
13. Triyatni M, Saunier B, Maruvada P, Davis AR, Ulianich L, Heller T, Patel A, Kohn LD, Liang TJ. Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J Virol 2002; 76: 9335-9344
14. Choo QL, Kuo G, Ralston R, Weiner A, Chien D, Van Nest G, Han J, Berger K, Thudium K, Kuo C, Kansopon J, McFarland J, Tabrizi A, Ching K, Moss B, Cummins LB, Houghton M, Muchmore E. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A 1994; 91: 1294-1298
15. Liu J, Zhu L, Zhang X, Lu M, Kong Y, Wang Y, Li G. Expression, purification, immunological characterization and application of Escherichia coli-derived hepatitis C virus E2 proteins. Biotechnol Appl Biochem 2001; 34(Pt 2): 109-119
16. Liu J, Kong Y, Zhu L, Wang Y, Li G. High-level expression of the C-terminal hydrophobic region of HCV E2 protein ectodomain in E. coli. Virus Genes 2002; 25: 5-13
17. Liu J, Zhang XX, Zhang SY, Lu. M, Kong YY, Wang Y, Li GD. Expression of hepatitis C virus E2 ectodomain in E. coli and its application in the detection of anti-E2 antibodies in human sera. Acta Biochim Biophys Sin 2004; 36: 57-63
18. Zhu LX, Liu J, Li YC, Kong YY, Staib C, Sutter G, Wang Y, Li GD. Full-length core sequence dependent complex-type glycosylation of hep atitis C virus E2 glycoprotein. World J Gastroenterol 2002; 8: 499-504
19. Wang CL, Zhu LX, Liu J, Zhang ZC, Wang Y, Li GD. Expression and characterization of hepatitis C Virus E2 glycoprotein fused to hepatitis B virus preS1 (21-47) fragment in CHO cells. Shengwuhuaxue Yu Shengwuwuli Xuebao 2002; 34: 400-404
20. Wang Y, Okamoto H, Tsuda F, Nagayama R, Tao QM, Mishiro S. Prevalence, genotypes, and an isolate (HC-C2) of hepatitis C virus in Chinese patients with liver disease. J Med Virol 1993: 40: 254-260
21. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press 2001
22. Li YC, Li GC, Kong YY, Wang Y, Wang Y, Wen YM. Expression of structural proteins of hepatitis C virus (HCV) in mammalian cells. Zhongguo Kexue 1998; 28: 204-210
23. Yan BS, Liao LY, Leou K, Chang YC, Syu WJ. Truncating the putative membrane association region circumvents the difficulty of expressing hepatitis C virus protein E1 in Escherichia coli. J Virol Methods 1994; 49: 343-351
24. Ciccaglione AR, Marcantonio C, Costantino A, Equestre M, Geraci A, Rapicetta M. Expression and membrane association of hepatitis C virus envelope 1 protein. Virus Genes 2000; 21: 223-226
25. Montigny C, Penin F, Lethias C, Falson P. Overcoming the toxicity of membrane peptide expression in bacteria by upstream insertion of Asp-Pro sequence. Biochim Biophys Acta 2004; 1660 53-65
26. Lorenzo LJ, Garcia O, Acosta-Rivero N, Dueñas-Carrera S, Martínez G, Álvarez-Obregón J, Pichardo D, Ramos A, Guerra I, Morales J. Expression and immunological evaluation of the Escherichia coli-derived hepatitis C virus envelope E1 protein. Biotechnol Appl Biochem 2000; 32(Pt 2): 137-143
27. Zhu J, Kong YY, Liu J, Zhang ZC, Wang Y, Li GD. Secretory expression of different C-terminal truncated HCV E1 proteins in mammalian cells and characterization of the expressed products. Shengwuhuaxue Yu Shengwuwuli Xuebao 2001; 33: 634-640
28. Fournillier A, Wychowski C, Boucreux D, Baumert TF, Meunier JC, Jacobs D, Muguet S, Depla E, Inchauspe G. Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites. J Virol 2001; 75 12088-12097
29. Hada H, Koide N, Hanafusa T, Sakaguchi K, Shinji T, Sasaki S, Oka T, Takayama N, Yumoto Y, Tsuji T. Detection by western blotting of an antibody to the hepatitis C virus E1 envelope protein in sera of patients with chronic liver disease. Acta Med Okayama 1992; 46: 365-370